SARS-CoV-2 Immunity

Overview

Journal Cell Mol Immunol

Date 2024 Jan 18

PMID 38238439

Authors

Antonio Bertoletti

Affiliations

Soon will be listed here.

Citing Articles

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.

Kimotho J, Sein Y, Sayed S, Shah R, Mwai K, Saleh M Wellcome Open Res. 2024; 8:350.

PMID: 39640868 PMC: 11617823. DOI: 10.12688/wellcomeopenres.19414.2.

References

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Sievers B, Cheng M, Csiba K, Meng B, Gupta R . SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks". Cell Mol Immunol. 2023; 21(2):171-183. PMC: 10805730. DOI: 10.1038/s41423-023-01104-y. View

Lapuente D, Winkler T, Tenbusch M . B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity. Cell Mol Immunol. 2023; 21(2):144-158. PMC: 10805925. DOI: 10.1038/s41423-023-01095-w. View

van Dorp L, Houldcroft C, Richard D, Balloux F . COVID-19, the first pandemic in the post-genomic era. Curr Opin Virol. 2021; 50:40-48. PMC: 8275481. DOI: 10.1016/j.coviro.2021.07.002. View

Fumagalli V, Iannacone M . The interplay of drug therapeutics and immune responses to SARS-CoV-2. Cell Mol Immunol. 2023; 21(2):197-200. PMC: 10805708. DOI: 10.1038/s41423-023-01098-7. View

Cankat S, Demael M, Swadling L . In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms. Cell Mol Immunol. 2023; 21(2):103-118. PMC: 10805787. DOI: 10.1038/s41423-023-01116-8. View

Bert N, Samandari T . Silent battles: immune responses in asymptomatic SARS-CoV-2 infection. Cell Mol Immunol. 2024; 21(2):159-170. PMC: 10805869. DOI: 10.1038/s41423-024-01127-z. View

Hoft M, Burgers W, Riou C . The immune response to SARS-CoV-2 in people with HIV. Cell Mol Immunol. 2023; 21(2):184-196. PMC: 10806256. DOI: 10.1038/s41423-023-01087-w. View

Chen Z, Yuan Y, Hu Q, Zhu A, Chen F, Li S . SARS-CoV-2 immunity in animal models. Cell Mol Immunol. 2024; 21(2):119-133. PMC: 10806257. DOI: 10.1038/s41423-023-01122-w. View

10.

Wellford S, Moseman E . Olfactory immune response to SARS-CoV-2. Cell Mol Immunol. 2023; 21(2):134-143. PMC: 10806031. DOI: 10.1038/s41423-023-01119-5. View

11.

Alves Pereira Neto T, Sidney J, Grifoni A, Sette A . Correlative CD4 and CD8 T-cell immunodominance in humans and mice: Implications for preclinical testing. Cell Mol Immunol. 2023; 20(11):1328-1338. PMC: 10616275. DOI: 10.1038/s41423-023-01083-0. View